Golden House (GOHO) fair value: what the stock is really worth
As of Nov 6, 2026: fair value (intrinsic value) of Golden House stock ILS 8.57, price ILS 10.07, that is 14.9% below the price, quality 66 out of 100. Rating: overvalued. Calculated from audited financials with 23 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Golden House
GOHO · TAOur calculation puts a fair price 15% below what the stock costs today.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 9, 2026.
How to read this chart
60‑month range 7.70 ILS – 28.22 ILS · fair‑value band 6.68 ILS – 11.14 ILS · the 10.07 ILS price screens above the 8.57 ILS fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 9, 2026.
Every Wednesday you see whether Golden House is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Golden House Ltd engages in the operation and management of sheltered housing centers for the elderly population in Israel.
Show moreShow less
It operates The Golden Age House, that contains housing units, as well as public areas, a lobby, a clubhouse, a library, cinema hall, computer room, synagogue, classrooms, lecture rooms, gym, and green garden terrace. The company also offers nursing care services.
In addition, it is involved in the renting of commercial buildings. The company was incorporated in 1982 and is headquartered in Tel Aviv-Yafo, Israel.
Stock analysis
Golden House (GOHO) currently trades at 10.07 ILS, while our model-based Fair Value estimate is 8.57 ILS, 15% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Asset-Based group reads highest at a median of 11.69 ILS per share, and 12 of the 23 models we run sit above the 10.07 ILS price.
Bear case: the Earnings-Based group reads lowest at 6.92 ILS, and 11 of the 23 models stay below the price. Data coverage for this calculation is high.
Scenario range: 6.68 ILS (bear) to 11.14 ILS (bull), the price of 10.07 ILS sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 66/100 (solid quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Golden House reported revenue of 48.9M ILS in FY2025 versus 56.2M ILS in FY2021, a compound −3.4%/yr. Reported net income was 7.3M ILS in FY2025, compounding −11.3%/yr from FY2021.
Key figures
Market cap 156M ILS Micro · P/E ratio 12.1 · P/S ratio 1.80 · EPS (TTM) 0.8300 ILS · Dividend yield 2.2% · Net margin 14.9% · Return on equity 3.7% · Return on assets (EBIT) 4.2% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 53 out of 100 (low confidence).
What moves the price
The share trades about 13% below its 52-week high and 4% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −1% fair-value upside, at −15%, GOHO screens richer than that median.
Fair Value models
All 23 models by family
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
Growth Forecast
GOHO screens overvalued: fair value 15% below the price. Compare with HCA Healthcare, Inc →
Compare Golden House with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Care Facilities · 234 stocks
Valuation Multiplesvs Medical Care Facilities median · lower = cheaper
Strength profile in five axes (Snowflake)
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- Piotroski F-Score screener with fair value
- Valuation of the Israel market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Fresenius Medical Care AG FMS | $23.40 | $46.55 | +99% | vs GOHO |
| Aier Eye Hospital Group 300015 | ¥9.01 | ¥10.88 | +21% | vs GOHO |
| DaVita Inc DVA | $191.35 | $218.90 | +14% | vs GOHO |
| HCA Healthcare, Inc HCA | $494.99 | $547.34 | +11% | vs GOHO |
| Tenet Healthcare Corporation THC | $283.33 | $279.20 | −1% | vs GOHO |
| The Ensign Group ENSG | $181.08 | $140.09 | −23% | vs GOHO |
| Encompass Health Corporation EHC | $137.54 | $94.81 | −31% | vs GOHO |
| Fresenius SE FRE | €52.48 | €34.77 | −34% | vs GOHO |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,446 | ₹5,234 | −38% | vs GOHO |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 215.00 SAR | 109.45 SAR | −49% | vs GOHO |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Golden House (GOHO) overvalued or undervalued?
What is the fair value of GOHO?
What is the quality score of GOHO?
What is the price target for Golden House (GOHO)?
What is the Golden House stock forecast for 2026?
What is the revenue of Golden House (GOHO)?
Does Golden House pay a dividend?
How much is the dividend of Golden House (GOHO) and when is the ex-dividend date?
What growth is priced into Golden House (GOHO)?
What discount rate (WACC) does the fair value of GOHO use?
What is a reverse DCF?
How much growth has Golden House (GOHO) delivered so far?
How fast is the sector of Golden House (GOHO) growing?
What is the free cash flow yield of Golden House (GOHO)?
What is the intrinsic value of Golden House (GOHO)?
Is Golden House stock overvalued or undervalued in 2026?
Is fair value the same as the market price of GOHO?
How much is Golden House worth?
What do the bullish and bearish scenarios say about GOHO?
What is the P/E ratio of GOHO?
How solid is the balance sheet of Golden House (GOHO)?
How far is GOHO from its 52-week high?
Which stocks are comparable to Golden House?
Is Golden House stock attractive at the current price?
How is the fair value of GOHO calculated?
Is it still worth investing in stocks now?
What is the share price of Golden House (GOHO)?
What should I pay attention to with Golden House right now?
Where does the earnings growth of Golden House (GOHO) come from?
Key figures of Golden House
How large is the market capitalisation of Golden House (GOHO)?
What is the P/S ratio of Golden House (GOHO)?
What are the earnings per share of Golden House (GOHO)?
What is the dividend yield of Golden House (GOHO)?
What is the net margin of Golden House (GOHO)?
What is the return on equity of Golden House (GOHO)?
What is the EBIT return on assets of Golden House (GOHO)?
What is the operating margin of Golden House (GOHO)?
How fast is revenue growing at Golden House (GOHO)?
How fast are earnings growing at Golden House (GOHO)?
How much net cash does Golden House (GOHO) hold?
Watch Golden House in the live analysis
One click puts Golden House on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.